| ［1］ |
Lee HL， Lee SW. The role of transjugular intrahepatic portosystemic shunt in patients with portal hypertension: advantages and pitfalls［J］.Clin Mol Hepatol， 2022， 28（2）: 121-134. DOI: 10.3350/cmh.2021.0239.
|
| ［2］ |
Ginès P， Krag A， Abraldes JG， et al. Liver cirrhosis［J］. Lancet， 2021，398（10308）: 1359-1376. DOI: 10.1016/s0140-6736（21）01374-x.
|
| ［3］ |
Kanwal F， Tansel A， Kramer JR， et al. Trends in 30-day and 1-year mortality among patients hospitalized with cirrhosis from 2004 to 2013［J］. Am J Gastroenterol， 2017， 112（8）: 1287-1297. DOI:10.1038/ajg.2017.175.
|
| ［4］ |
Boike JR， Thornburg BG， Asrani SK， et al. North American practicebased recommendations for transjugular intrahepatic portosystemic shunts in portal hypertension［J］. Clin Gastroenterol Hepatol， 2022，20（8）: 1636-1662.e36. DOI: 10.1016/j.cgh.2021.07.018.
|
| ［5］ |
de Franchis R， Faculty BV. Expanding consensus in portal hypertension: report of the Baveno VI Consensus Workshop:stratifying risk and individualizing care for portal hypertension［J］. J Hepatol， 2015， 63（3）: 743-752. DOI: 10.1016/j.jhep.2015.05.022.
|
| ［6］ |
Silva-Junior G， Baiges A， Turon F， et al. The prognostic value of hepatic venous pressure gradient in patients with cirrhosis is highly dependent on the accuracy of the technique［J］. Hepatology， 2015，62（5）: 1584-1592. DOI: 10.1002/hep.28031.
|
| ［7］ |
中国门静脉高压诊断与监测研究组（CHESS）， 中华医学会消化病学分会微创介入协作组， 中国医师协会介入医师分会急诊介入专委会， 等. 中国肝静脉压力梯度临床应用专家共识（2018年版）［J］. 实用肝脏病杂志， 2019， 22（3）: 321-332. DOI: 10.3969/j.issn.1672-5069.2019.03.005.Chinese Portal Hypertension Diagnosis and Monitoring Study Group（CHESS），Minimally Invasive Intervention Collaborative Group of Chinese Society of Gastroenterology，Emergency Intervention Committee of Chinese College of Interventionalists，et al. Consensus on clinical application of hepatic venous pressure gradient in China（2018）［J］. J Pract Hepatol， 2019， 22（3）: 321-332. DOI: 10.3969/j.issn.1672-5069.2019.03.005.
|
| ［8］ |
Tey TT， Gogna A， Irani FG， et al. Application of a standardised protocol for hepatic venous pressure gradient measurement improves quality of readings and facilitates reduction of variceal bleeding in cirrhotics［J］. Singapore Med J， 2016， 57（3）: 132-137. DOI: 10.11622/smedj.2016054.
|
| ［9］ |
Garcia-Tsao G， Abraldes JG， Berzigotti A， et al. Portal hypertensive bleeding in cirrhosis: risk stratification， diagnosis， and management:2016 practice guidance by the American association for the study of liver diseases［J］. Hepatology， 2017， 65（1）: 310-335. DOI: 10.1002/hep.28906.
|
| ［10］ |
Tripathi D， Stanley AJ， Hayes PC， et al. U.K. guidelines on the management of variceal haemorrhage in cirrhotic patients［J］. Gut，2015， 64（11）: 1680-1704. DOI: 10.1136/gutjnl-2015-309262.
|
| ［11］ |
Groszmann RJ， Garcia-Tsao G， Bosch J， et al. Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis［J］. N Engl J Med， 2005， 353（21）: 2254-2261. DOI: 10.1056/NEJMoa044456.
|
| ［12］ |
Ripoll C， Groszmann R， Garcia-Tsao G， et al. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis［J］. Gastroenterology， 2007， 133（2）: 481-488.DOI: 10.1053/j.gastro.2007.05.024.
|
| ［13］ |
Asenbaum U， Ba-Ssalamah A， Mandorfer M， et al. Effects of portal hypertension on gadoxetic acid-enhanced liver magnetic resonance:diagnostic and prognostic implications［J］. Invest Radiol， 2017， 52（8）:462-469. DOI: 10.1097/RLI.0000000000000366.
|
| ［14］ |
Talakić E， Schaffellner S， Kniepeiss D， et al. CT perfusion imaging of the liver and the spleen in patients with cirrhosis: is there a correlation between perfusion and portal venous hypertension？［J］. Eur Radiol，2017， 27（10）: 4173-4180. DOI: 10.1007/s00330-017-4788-x.
|
| ［15］ |
Ruíz-del-Árbol L， Achécar L， Serradilla R， et al. Diastolic dysfunction is a predictor of poor outcomes in patients with cirrhosis，portal hypertension， and a normal creatinine［J］. Hepatology， 2013，58（5）: 1732-1741. DOI: 10.1002/hep.26509.
|
| ［16］ |
中国医师协会介入医师分会. 中国门静脉高压经颈静脉肝内门体分流术临床实践指南（2019版）［J］. 中华医学杂志， 2019， 99（45）:3534-3546. DOI: 10.3760/cma.j.issn.0376-2491.2019.45.003.Chinese College of Interventionalists. CCI clinical practice guidelines:management of TIPS for portal hypertension （2019 edition）［J］.Natl Med J China， 2019， 99（45）: 3534-3546. DOI: 10.3760/cma.j.issn.0376-2491.2019.45.003.
|
| ［17］ |
Sinha I， Goldman DT， Patel RS， et al. Advanced techniques for accessing the portal vein during transjugular intrahepatic portosystemic shunt creation［J］. Semin Intervent Radiol， 2023， 40（1）:79-86. DOI: 10.1055/s-0043-1767688.
|
| ［18］ |
Luo X， Zhao M， Wang X， et al. Long-term patency and clinical outcome of the transjugular intrahepatic portosystemic shunt using the expanded polytetrafluoroethylene stent-graft［J］. PLoS One， 2019，14（2）: e0212658. DOI: 10.1371/journal.pone.0212658.
|
| ［19］ |
李松蔚， 李迎春， 闫东， 等. Fluency覆膜支架行TIPS术后支架狭窄原因分析［J］. 介入放射学杂志， 2015， 24（12）: 1047-1051. DOI:10.3969/j.issn.1008-794X.2015.12.006.Li SW， Li YC， Yan D， et al. Transjugular intrahepatic portosystemic shunt with Fluency covered stent: analysis of the causes of stent stenosis［J］. J Interv Radiol， 2015， 24（12）: 1047-1051. DOI: 10.3969/j.issn.1008-794X.2015.12.006.
|
| ［20］ |
胡朋， 陈斯良， 罗泽龙， 等. 采用裸支架联合覆膜支架建立经颈静脉肝内门体分流术的中远期疗效［J］. 中国介入影像与治疗学，2016， 13（7）: 394-397. DOI: 10.13929/j.1672-8475.2016.07.002.Hu P， Chen SL， Luo ZL， et al. Medium-long efficacy in transjugular intrahepatic portalsystemic shunts utilizing bare and covered stent［J］.Chin J Interv Imag Ther， 2016， 13（7）: 394-397. DOI: 10.13929/j.1672-8475.2016.07.002.
|
| ［21］ |
孙旻煌， 李迎春， 李松蔚， 等. Viatorr支架在TIPS治疗中的应用［J］.介入放射学杂志， 2019， 28（2）: 166-169. DOI: 10.3969/j.issn.1008-794X.2019.02.015.Sun MH， Li YC， Li SW， et al. Application of Viatorr stent in transjugular intrahepatic portosystemic shunt treatment［J］. J Interv Radiol， 2019， 28（2）: 166-169. DOI: 10.3969/j.issn.1008-794X.2019.02.015.
|
| ［22］ |
Saad WEA， Darwish WM， Davies MG， et al. Stent-grafts for transjugular intrahepatic portosystemic shunt creation: specialized TIPS stent-graft versus generic stent-graft/bare stent combination［J］.J Vasc Interv Radiol， 2010， 21（10）: 1512-1520. DOI: 10.1016/j.jvir.2010.06.009.
|
| ［23］ |
Geeroms B， Laleman W， Laenen A， et al. Expanded polytetrafluoroethylene-covered stent-grafts for transjugular intrahepatic portosystemic shunts in cirrhotic patients: long-term patency and clinical outcome results［J］. Eur Radiol， 2017， 27（5）: 1795-1803. DOI:10.1007/s00330-016-4570-5.
|
| ［24］ |
Wang Q， Lv Y， Bai M， et al. Eight millimetre covered TIPS does not compromise shunt function but reduces hepatic encephalopathy in preventing variceal rebleeding［J］. J Hepatol， 2017， 67（3）: 508-516.DOI: 10.1016/j.jhep.2017.05.006.
|
| ［25］ |
Miraglia R， Maruzzelli L， Tuzzolino F， et al. Transjugular intrahepatic portosystemic shunts in patients with cirrhosis with refractory ascites:comparison of clinical outcomes by using 8- and 10-mm PTFE-covered stents［J］. Radiology， 2017， 284（1）: 281-288. DOI: 10.1148/radiol.2017161644.
|
| ［26］ |
Trebicka J， Bastgen D， Byrtus J， et al. Smaller-diameter covered transjugular intrahepatic portosystemic shunt stents are associated with increased survival［J］. Clin Gastroenterol Hepatol， 2019， 17（13）:2793-2799.e1. DOI: 10.1016/j.cgh.2019.03.042.
|
| ［27］ |
文彦.TIPS术中不同直径覆膜支架对肝硬化门静脉高压疗效和安全性的Meta分析［D］. 衡阳: 南华大学， 2020. DOI: 10.27234/d.cnki.gnhuu.2020.000789.Wen Y. A Meta-analysis comparing covered stents with different diameter in transjugular intrahepatic portosystemic shunt（TIPS）for the treatment of portal hypertension in patients［D］. Hengyang:University of South China， 2020. DOI: 10.27234/d.cnki.gnhuu.2020.000789.
|
| ［28］ |
Dariushnia SR， Haskal ZJ， Midia M， et al. Quality improvement guidelines for transjugular intrahepatic portosystemic shunts［J］. J Vasc Interv Radiol， 2016， 27（1）: 1-7. DOI: 10.1016/j.jvir.2015.09.018.
|
| ［29］ |
Duller D， Kniepeiss D， Lackner C， et al. Biliary obstruction as a complication of transjugular intrahepatic portosystemic shunt［J］.Liver Transpl， 2009， 15（5）: 556-557. DOI: 10.1002/lt.21608.
|
| ［30］ |
Liu K， Fan XX， Wang XL， et al. Delayed liver laceration following transjugular intrahepatic portosystemic shunt for portal hypertension［J］. World J Gastroenterol， 2012， 18（48）: 7405-7408.DOI: 10.3748/wjg.v18.i48.7405.
|
| ［31］ |
Suhocki PV， Lungren MP， Kapoor B， et al. Transjugular intrahepatic portosystemic shunt complications: prevention and management［J］.Semin Intervent Radiol， 2015， 32（2）: 123-132. DOI: 10.1055/s-0035-1549376.
|
| ［32］ |
Haskal ZJ， Pentecost MJ， Rubin RA. Hepatic arterial injury after transjugular intrahepatic portosystemic shunt placement: report of two cases［J］. Radiology， 1993， 188（1）: 85-88. DOI: 10.1148/radiology.188.1.8511322.
|
| ［33］ |
Brountzos EN， Alexopoulou E， Koskinas I， et al. Intraperitoneal portal vein bleeding during transjugular intrahepatic portosystemic shunt: treatment with stent-graft placement［J］. AJR Am J Roentgenol，2000， 174（1）: 132-134. DOI: 10.2214/ajr.174.1.1740132.
|
| ［34］ |
Larrue H， D’Amico G， Olivas P， et al. TIPS prevents further decompensation and improves survival in patients with cirrhosis and portal hypertension in an individual patient data meta-analysis［J］. J Hepatol， 2023， 79（3）: 692-703. DOI: 10.1016/j.jhep.2023.04.028.
|
| ［35］ |
Gaba RC， Khiatani VL， Grace Knuttinen M， et al. Comprehensive review of TIPS technical complications and how to avoid them［J］.AJR Am J Roentgenol， 2011， 196（3）: 675-685. DOI: 10.2214/AJR.10.4819.
|
| ［36］ |
Sanyal AJ， Freedman AM， Shiffman ML， et al. Portosystemic encephalopathy after transjugular intrahepatic portosystemic shunt:results of a prospective controlled study［J］. Hepatology， 1994， 20（1 Pt 1）: 46-55. DOI: 10.1016/0270-9139（94）90133-3.
|
| ［37］ |
Pereira K， Carrion AF， Martin P， et al. Current diagnosis and management of post-transjugular intrahepatic portosystemic shunt refractory hepatic encephalopathy［J］. Liver Int， 2015， 35（12）: 2487-2494. DOI: 10.1111/liv.12956.
|
| ［38］ |
Riggio O， Nardelli S， Moscucci F， et al. Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt［J］. Clin Liver Dis，2012， 16（1）: 133-146. DOI: 10.1016/j.cld.2011.12.008.
|
| ［39］ |
American Association for the Study of Liver Diseases， European Association for the Study of the Liver. Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by the European Association for the Study of the Liver and the American Association for the Study of Liver Diseases［J］. J Hepatol， 2014， 61（3）: 642-659.DOI: 10.1016/j.jhep.2014.05.042.
|
| ［40］ |
Thabut D， Bouzbib C， Meunier L， et al. Diagnosis and management of hepatic encephalopathy: the French recommendations［J］. Liver Int，2023， 43（4）: 750-762. DOI: 10.1111/liv.15510.
|
| ［41］ |
Campagna F， Montagnese S， Ridola L， et al. The animal naming test: an easy tool for the assessment of hepatic encephalopathy［J］.Hepatology， 2017， 66（1）: 198-208. DOI: 10.1002/hep.29146.
|
| ［42］ |
Labenz C， Beul L， Toenges G， et al. Validation of the simplified Animal Naming Test as primary screening tool for the diagnosis of covert hepatic encephalopathy［J］. Eur J Intern Med， 2019， 60: 96-100. DOI: 10.1016/j.ejim.2018.08.008.
|
| ［43］ |
Gaba RC， Lakhoo J. What constitutes liver failure after transjugular intrahepatic portosystemic shunt creation？ A proposed definition and grading system［J］. Ann Hepatol， 2016， 15（2）: 230-235. DOI:10.5604/16652681.1193719.
|
| ［44］ |
Chung HH， Razavi MK， Sze DY， et al. Portosystemic pressure gradient during transjugular intrahepatic portosystemic shunt with Viatorr stent graft: what is the critical low threshold to avoid medically uncontrolled low pressure gradient related complications？［J］. J Gastroenterol Hepatol， 2008， 23（1）: 95-101.DOI: 10.1111/j.1440-1746.2006.04697.x.
|
| ［45］ |
Inchingolo R， Posa A， Mariappan M， et al. Transjugular intrahepatic portosystemic shunt for Budd-Chiari syndrome: a comprehensive review［J］. World J Gastroenterol， 2020， 26（34）: 5060-5073. DOI:10.3748/wjg.v26.i34.5060.
|
| ［46］ |
Darcy M. Evaluation and management of transjugular intrahepatic portosystemic shunts［J］. AJR Am J Roentgenol， 2012， 199（4）: 730-736. DOI: 10.2214/AJR.12.9060.
|
| ［47］ |
杨帆， 曾懿. 双能量CT虚拟单能谱成像技术在TIPS术后支架评估中的应用［J］. 中国中西医结合影像学杂志， 2019， 17（3）: 266-268.DOI: 10.3969/j.issn.1672-0512.2019.03.014.Yang F， Zeng Y. Application of monochromatic imaging in postoperative evaluation of the patients with TIPS using dual energy CT［J］. Chin Imag J Integr Tradit West Med， 2019， 17（3）: 266-268.DOI: 10.3969/j.issn.1672-0512.2019.03.014.
|
| ［48］ |
苏蕾， 梁盼， 吕培杰， 等. 宽体探测器CT多物质伪影降低技术在经颈静脉肝内门体分流术及栓塞术后门静脉血管成像中的应用价值［J］. 中华医学杂志， 2019， 99（1）: 44-48. DOI: 10.3760/cma.j.issn.0376-2491.2019.01.010.Su L， Liang P， Lyu PJ， et al. Application of a multi-material artifact reduction algorithm in a wide-detector CT in the evaluation of the portal venous angiography of postoperative TIPS and embolization［J］.Natl Med J China， 2019， 99（1）: 44-48. DOI: 10.3760/cma.j.issn.0376-2491.2019.01.010.
|
| ［49］ |
Owen JW， Saad NE， Foster G， et al. The feasibility of using volumetric phase-contrast MR imaging （4D flow） to assess for transjugular intrahepatic portosystemic shunt dysfunction［J］. J Vasc Interv Radiol，2018， 29（12）: 1717-1724. DOI: 10.1016/j.jvir.2018.07.022.
|
| ［50］ |
Gharib AM， Han MAT， Meissner EG， et al. Magnetic resonance elastography shear wave velocity correlates with liver fibrosis and hepatic venous pressure gradient in adults with advanced liver disease［J］. Biomed Res Int， 2017， 2017: 2067479. DOI: 10.1155/2017/2067479.
|